SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-022601
Filing Date
2013-04-17
Accepted
2013-04-17 21:41:43
Documents
1
Period of Report
2013-04-16

Document Format Files

Seq Description Document Type Size
1 rrd376778.html 4  
1 rrd376778.xml 4 19084
  Complete submission text file 0001181431-13-022601.txt   21587
Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting) CIK: 0001452907 (see all company filings)

State of Incorp.: E9
Type: 4 | Act: 34 | File No.: 001-35869 | Film No.: 13768061

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 410-244-0115
NEA 13 GP, Ltd (Reporting) CIK: 0001460751 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35869 | Film No.: 13768059

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 410-244-0115
NEA Partners 13, Limited Partnership (Reporting) CIK: 0001460752 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35869 | Film No.: 13768060

Mailing Address 707 STATE ROAD NEW JERSEY NJ 08540
Business Address 707 STATE ROAD NEW JERSEY NJ 08540 908-741-4323
Omthera Pharmaceuticals, Inc. (Issuer) CIK: 0001477598 (see all company filings)

IRS No.: 263797738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations